Edward Fox
- Pathology and Forensic Medicine top 0.1%
- Multiple Sclerosis Research Studies 76
- Neurology top 0.5%
- Peripheral Neuropathies and Disorders 24
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies 16
- Systemic Lupus Erythematosus Research 8
- Immunology top 2%
- Immunotherapy and Immune Responses 19
- Oncology top 2%
- Polyomavirus and related diseases 14
-
- Sarcoma Diagnosis and Treatment 15
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- David MargolinAlasdair ColesKrzysztof SelmajD. A. S. CompstonStephen LakeDouglas L. ArnoldEva HavrdováJeffrey Cohen
- Journals
- Neurology (50 papers)Clinical Orthopaedics and Related Research (9 papers)Journal of the Neurological Sciences (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Edward Fox
150 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Pathology and Forensic Medicine 3.6k
- Neurology 1.5k
- Rheumatology 1.3k
- Immunology 1.2k
- Oncology 1.5k
Countries citing papers authored by Edward Fox
This map shows the geographic impact of Edward Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Fox more than expected).
Fields of papers citing papers by Edward Fox
This network shows the impact of papers produced by Edward Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Fox. The network helps show where Edward Fox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2019 | 3 | |
| 10 | 2017 | 2 | |
| 11 | Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I). | 2016 | 7 |
| 12 | 2016 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2015 | 1 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2008 | 2 |
About Edward Fox
Edward Fox is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology, having authored 156 papers that have together received 6.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (76 papers), Peripheral Neuropathies and Disorders (24 papers), Immunotherapy and Immune Responses (19 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Sarcoma Diagnosis and Treatment (15 papers), Polyomavirus and related diseases (14 papers), Acute Lymphoblastic Leukemia research (11 papers) and Systemic Lupus Erythematosus Research (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.6k citations), Neurology (1.5k citations) and Rheumatology (1.3k citations). Edward Fox has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David Margolin, Alasdair Coles, Krzysztof Selmaj, D. A. S. Compston, Stephen Lake, Douglas L. Arnold, Eva Havrdová, Jeffrey Cohen, Michael Panzara and Christian Confavreux. Their work appears in journals such as Neurology, Clinical Orthopaedics and Related Research, Journal of the Neurological Sciences, Geriatric Orthopaedic Surgery & Rehabilitation and Multiple Sclerosis Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.